1. Home
  2. VCIC vs SMLR Comparison

VCIC vs SMLR Comparison

Compare VCIC & SMLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCIC
  • SMLR
  • Stock Information
  • Founded
  • VCIC 2024
  • SMLR 2007
  • Country
  • VCIC United States
  • SMLR United States
  • Employees
  • VCIC N/A
  • SMLR N/A
  • Industry
  • VCIC
  • SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • VCIC
  • SMLR Health Care
  • Exchange
  • VCIC NYSE
  • SMLR Nasdaq
  • Market Cap
  • VCIC 293.0M
  • SMLR 289.5M
  • IPO Year
  • VCIC 2024
  • SMLR 2014
  • Fundamental
  • Price
  • VCIC $10.03
  • SMLR $64.53
  • Analyst Decision
  • VCIC
  • SMLR
  • Analyst Count
  • VCIC 0
  • SMLR 0
  • Target Price
  • VCIC N/A
  • SMLR N/A
  • AVG Volume (30 Days)
  • VCIC 8.7K
  • SMLR 1.1M
  • Earning Date
  • VCIC 01-01-0001
  • SMLR 11-04-2024
  • Dividend Yield
  • VCIC N/A
  • SMLR N/A
  • EPS Growth
  • VCIC N/A
  • SMLR N/A
  • EPS
  • VCIC N/A
  • SMLR 2.04
  • Revenue
  • VCIC N/A
  • SMLR $58,938,000.00
  • Revenue This Year
  • VCIC N/A
  • SMLR N/A
  • Revenue Next Year
  • VCIC N/A
  • SMLR N/A
  • P/E Ratio
  • VCIC N/A
  • SMLR $29.36
  • Revenue Growth
  • VCIC N/A
  • SMLR N/A
  • 52 Week Low
  • VCIC $9.96
  • SMLR $20.88
  • 52 Week High
  • VCIC $10.03
  • SMLR $79.45
  • Technical
  • Relative Strength Index (RSI)
  • VCIC N/A
  • SMLR 62.46
  • Support Level
  • VCIC N/A
  • SMLR $57.33
  • Resistance Level
  • VCIC N/A
  • SMLR $65.97
  • Average True Range (ATR)
  • VCIC 0.00
  • SMLR 8.13
  • MACD
  • VCIC 0.00
  • SMLR -0.56
  • Stochastic Oscillator
  • VCIC 0.00
  • SMLR 45.65

About VCIC VINE HILL CAP INVT CORP

Vine Hill Capital Investment Corp is a blank check company.

About SMLR Semler Scientific Inc.

Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.

Share on Social Networks: